Metastatic Merkel Cell Carcinoma Masquerading as multiple immune-related Adverse Events

2020
Merkel Cell Carcinoma
Author

Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Thomas G. Neilan, Tatyana Sharova, David M. Miller

Published

September 29, 2020

Doi
Abstract
We present a case of MCC masquerading as Multiple Immune-Related Adverse Events

Abstract:

Merkel cell carcinoma is a rare cutaneous neuroendocrine carcinoma with a high rate of regional and distant metastasis and mortality. Here, we report a novel case of Merkel cell carcinoma which presented as a primary lesion to the left cheek with regional lymph node involvement and was treated with pembrolizumab and radiation. Widely metastatic disease eventually revealed on autopsy clinically mimicked immune-related organ insult leading to management with immunosuppressants. The patient also had a biopsy-confirmed immune-related cutaneous adverse event during admission. The case highlights a rare circumstance in which disease progression masqueraded as multiple immune-related end-organ adverse events. Contribution of on-target anti-PD-1 toxicity remains a possibility.